H.C. Wainwright analyst Patrick Trucchio raised the firm’s price target on Arrowhead (ARWR) to $80 from $60 and keeps a Buy rating on the ...
Shares of Janux Therapeutics Inc. surged over 54% on Tuesday afternoon, reaching levels not seen since May and breaking a ...
H.C. Wainwright analyst Mike Colonnese says CleanSpark (CLSK) reported solid fiscal Q4 results and reiterated its prior calendar year-end 2024 ...
Purple Biotech shares are trading lower by 28% during Tuesday's session. The company announced a $2.8 million offering.
H.C. Wainwright lowered the firm’s price target on Splash Beverage (SBEV) to 50c from $1 and keeps a Buy rating on the shares ...
As of the latest trading close, AKBA, a Healthcare sector stock, is trading -14.11% below its 52-week high but remains 166.25% above its 52-week low. The Average True Range (ATR) (14 days) of 0.1 ...
On Friday, Energy Fuels Inc (UUUU) stock saw a modest uptick, ending the day at $7.29 which represents a slight increase of $0.49 or 7.21% from the prior close of $6.8. The stock opened at $7.1 and ...
The gross proceeds to the Company from the offering are expected to be approximately $2.8 million, before deducting the ...
The Company clarified that they are not obligated to sell any Shares under this agreement. H.C. Wainwright & Co., LLC will act to sell the Shares based on electroCore’s instructions and within the ...
H.C. Wainwright analyst Andrew Fein lowered the firm’s price target on Alector (ALEC) to $7 from $35 and keeps a Buy rating ...
Thanks to the Securities and Exchange Commission, you don't have to. Artificial intelligence (AI) has been the stock market's ...
H.C. Wainwright raised the firm’s price target on BridgeBio (BBIO) to $49 from $43 and keeps a Buy rating on the shares. Acoramidis received regulatory approval with the label underscoring ...